Phase II A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia
Latest Information Update: 05 Jun 2025
At a glance
- Drugs APG-157 (Primary)
- Indications Oropharyngeal dysplasia
- Focus Proof of concept; Therapeutic Use
Most Recent Events
- 06 Jun 2023 Planned End Date changed from 1 Jul 2028 to 24 May 2028.
- 06 Jun 2023 Planned primary completion date changed from 1 Jul 2027 to 24 May 2027.
- 06 Jun 2023 Status changed from not yet recruiting to recruiting.